Motivation: Alzheimer's disease involves neurotoxic amyloid-beta (Aβ) plaques. In mice, impaired CSF clearance reduces Aβ removal by 70%. Sleep may boost CSF clearance by expanding extracellular space, potentially affecting CSF flow velocity. Goal(s): The impact of sleep on CSF flow in humans remains unclear due to limited non-invasive imaging. Approach: Using sodium (23Na) MRI, we measured extracellular volume in 29 healthy brains, with sleep stages monitored via MRI-compatible EEG. Results: We observed significant differences in CSF flow velocity between gray matter (GM) and white matter (WM) during sleep stages W, N2, and N3, though no clear velocity trends across stages were found. Impact: This work may clarify sleep's role in Aβ clearance in humans.
Lin et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: